The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients  M.M. Santoro, D. Armenia, L. Fabeni,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
L.H. Su, T.L. Wu, C.H. Chiu  Clinical Microbiology and Infection 
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
V. Bordoni, M. Bibas, I. Abbate, D. Viola, G. Rozera, C. Agrati, A
Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A   M. Surdo, C. Alteri, M.C. Puertas, P. Saccomandi,
L. S. Tzouvelekis, A. Markogiannakis, E. Piperaki, M. Souli, G. L
L. Boyanova  Clinical Microbiology and Infection 
Influence of hepatitis C and hepatitis G virus co-infection on viral and cellular dynamics in patients infected with human immunodeficiency virus following.
Gut bacterial microbiota and obesity
L.H. Su, T.L. Wu, C.H. Chiu  Clinical Microbiology and Infection 
Approach to diagnosis of infective endocarditis
Herpes zoster in non-hospitalized children
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Association of CD209L tandem repeats polymorphism with susceptibility to human immunodeficiency virus-1 infection, disease progression, and treatment.
Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era  T.I. Pedersen, M. Howitz, C. Østergaard  Clinical.
E. Bronska, J. Kalmusova, O. Dzupova, V. Maresova, P. Kriz, J. Benes 
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Paradoxical immune reconstitution inflammatory syndrome associated with cryptococcal meningitis in China: a 5-year retrospective cohort study  S. Yan,
R. Cantón  Clinical Microbiology and Infection 
Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral.
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy  M. Pollicita, C. Alteri, M.C.
Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A   M. Surdo, C. Alteri, M.C. Puertas, P. Saccomandi,
G. Griesinger, G. Gille, C. Klapp, S. von Otte, K. Diedrich 
Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013  L.E.B. Nabarro, R.A. Lever, M. Armstrong,
Potential risk factors for infection with Candida spp
Trends in length of stay, mortality and readmission among patients with community- acquired bacteraemia  M. Søgaard, R.W. Thomsen, R.B. Bang, H.C. Schønheyder,
Clinical Microbiology and Infection
Vector control: a cornerstone in the malaria elimination campaign
Systematic review or meta-analysis
Tropheryma whipplei in children with diarrhoea in rural Ghana
Junior doctors' knowledge and perceptions of antibiotic resistance and prescribing: a survey in France and Scotland  C. Pulcini, F. Williams, N. Molinari,
Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral.
Training for the infectious diseases speciality in Norway
G. Höffken  Clinical Microbiology and Infection 
Retrospective study of CMV retinitis in patients with AIDS
Laboratory diagnosis and biosafety issues of biological warfare agents
Detection of interleukin-2 in addition to interferon-γ discriminates active tuberculosis patients, latently infected individuals, and controls  R. Biselli,
Elements of design: the knowledge on which we build
The critical influence of the intermediate category on interpretation errors in revised EUCAST and CLSI antimicrobial susceptibility testing guidelines 
Levofloxacin in the treatment of ventilator-associated pneumonia
Metagenomics and probiotics
Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study  J.-Y. Feng, S.-F. Huang, W.-Y. Ting, Y.-C.
Transmission permeability of tuberculosis involving immigrants, revealed by a multicentre analysis of clusters  N. Alonso Rodríguez, S. Andrés, E. Bouza,
Previously unknown species of Aspergillus
Detection of, and frequent co-infection with, human bocavirus in faecal specimens from children in Wuhan, China  Y. Huang, P. Mao, H. Wang  Clinical Microbiology.
U. Sagel, R.T. Mikolajczyk, A. Krämer 
Laboratory diagnosis of Clostridium difficile disease
Systematic review of antibiotic consumption in acute care hospitals
Efficacy of environmental measures to decrease the risk of hospital-acquired aspergillosis in patients hospitalised in haematology wards  P. Berthelot,
Training in infectious diseases and tropical medicine in Britain
R. Slinger, I. Moldovan, N. Barrowman, F. Chan 
Clinical infection services—the Leiden experience
F. Ceccherini-Silberstein, V. Cento, V. Calvez, C.-F. Perno 
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
Volume 373, Issue 9672, Pages (April 2009)
Statin use and clinical outcomes among pneumonia patients
Tuberculosis in HIV-infected patients: a comprehensive review
Lymphocyte subset numbers depend on the bacterial origin of sepsis
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Are we losing the fight against malaria one more time?
Typing of Clostridium difficile
Overall trends in CD4 counts and plasma viremia in an urban clinic since the introduction of highly active antiretroviral therapies  J.C. Martín, V Soriano,
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Abstracts Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients  M.M. Santoro, D. Armenia, L. Fabeni, M. Santoro, C. Gori, F. Forbici, V. Svicher, A. Bertoli, L. Dori, M. Surdo, E. Balestra, G. Palamara, E. Girardi, G. Angarano, M. Andreoni, P. Narciso, A. Antinori, F. Ceccherini-Silberstein, C.F. Perno  Clinical Microbiology and Infection  Volume 18, Issue 8, Pages E289-E298 (August 2012) DOI: 10.1111/j.1469-0691.2012.03905.x Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Proportion of patients infected with X4- and R5-tropic viruses. (Panel a) Antiretroviral therapy (ART)-naive patients. (Panel b) ART-experienced patients. The proportions of R5-infected (FPR>10%, in white) and X4-infected (FPR≤10%, grey lines) patients are indicated in the pie plots. Exploded bars represent the stratification of X4-infected patients according to 2% FPR-X4 ranges (FPR 2–10%, in dark grey; FPR≤2%, in black). Clinical Microbiology and Infection 2012 18, E289-E298DOI: (10.1111/j.1469-0691.2012.03905.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Proportion of X4- and R5-infected patients according to different CD4 cell count ranges. (Panel a) Proportion of antiretroviral therapy (ART)-naive patients stratified for different CD4 cell count ranges. (Panel b) Proportion of ART-experienced patients stratified for different CD4 cell count ranges. Bar plots indicate the proportion of X4-infected patients with FPR ≤2% (in black) or FPR 2–10% (in grey), and the proportion of R5-infected patients (in white), all of them stratified for different CD4 cell count ranges. Tables inserted in the figure indicate the p values obtained by chi-square test for trend used to calculate potential differences in the proportion of patients for the following groups: (i) patients with FPR ≤2% vs. those with FPR >2%; (ii) patients with FPR 2–10% vs. those with FPR >10%, (iii) patients with FPR ≤2% vs. those with FPR >2%. In bold are reported p values considered statistically significant (<0.05). Clinical Microbiology and Infection 2012 18, E289-E298DOI: (10.1111/j.1469-0691.2012.03905.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 3 Risk of having CD4 cell count ≤200 cells/mm3 by false-positive rate ranges in antiretroviral therapy (ART)-experienced and ART-naive patients. Forest plots represent the odds ratios (with 95% confidence interval) of having CD4 cell count ≤200 cells mm3 calculated comparing several categories of patients having different FPR ranges. On the left panel are ART-naive patients; on the right panel are ART-experienced patients; p values were obtained by Fisher's exact test and were considered statistically significant at a threshold of 0.05. Clinical Microbiology and Infection 2012 18, E289-E298DOI: (10.1111/j.1469-0691.2012.03905.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions